InvestorsHub Logo
Followers 148
Posts 7871
Boards Moderated 2
Alias Born 03/15/2002

Re: None

Friday, 11/22/2002 9:17:38 AM

Friday, November 22, 2002 9:17:38 AM

Post# of 14671
More news:

IBCI Enters into a Licensing and Distribution Agreement with Northeast


RELATED SYMBOLS: (IBCL)

ATLANTA, Nov 22, 2002 /PRNewswire-FirstCall via COMTEX/ -- International
BioChemical Industries, Inc. (OTC Bulletin Board: IBCL) is pleased to announce
the signing of an exclusive licensing and distribution agreement with Bio Kleen,
Inc. for the Marine and RV retail market in The United States. The distributor
has placed an initial order for 10,000 pounds of our antimicrobial active
ingredient, with potential additional orders in the near term. Their retailer is
in the process of sub registering our product and plans to launch their new
product line in January 2003. Under the new format of the distribution model,
there are performance criteria that are required to be met; however, the program
is not based on guaranteed revenue amounts. The program is based on a working
relationship between the two companies to meet the objectives of both IBCI and
Bio Kleen. Bio Kleen will provide IBCI status reports and plans on a regular
basis, including projected volumes by quarter as part of the new distribution
program. Ms. Deirdre Baker stated, "After months of negotiation we are very
excited about the opportunity to work closely with Bio Kleen." Bio Kleen
develops, markets, and distributes a number of products to the wastewater,
remediation and health/pharmaceutical retail markets.

About, International BioChemical Industries, Inc.:

International BioChemical Industries, Inc. is a Norcross, Georgia-based emerging
growth company focused in biotechnology and antimicrobial products. Its core
business is committed to the discovery, development, marketing and sale of
surface-modifying antimicrobial and biostatic products. The company's
antimicrobial technology is a revolutionary alternative to conventional
sanitizers, disinfectants, bleaches, biocides or preservatives primarily because
it kills bacteria, including HIV, on contact and can remain active for extended
time periods. To date, BioShield has received three US patents and eight EPA
registrations, including the first U.S. germ killer and disinfectant against
Salmonella cholerasuis, Staphylococcus aureus and other microorganisms. The
company has developed several alliances in different industries, such as
healthcare, textiles and storm water. Further information on IBCI and its line
of products can be found by visiting the firm's web site at
http://www.bioshield.com, or by calling Deirdre Baker at 1-770-925-3653.

Safe Harbor/Forward-looking Statements: Statements in this news release that are
not historical are forward-looking statements. These forward-looking statements
are subject to certain risks and uncertainties that could cause actual results
to differ materially from those anticipated in any forward-looking statements,
all of which are difficult to predict and many of which are beyond the control
of the company, including areas such as: developing technologies; dependence on
collaborative partners; the inherent complexity and uncertainty regarding the
development of products; early-stage development of IBCI the result of research
and development efforts; future capital needs; uncertainty of additional
funding; government regulations; and other factors which are detailed in the
company's periodic reports and registration statements filed with the Securities
and Exchange Commission. IBCI does not undertake to revise or update any
forward-looking statement to reflect events or circumstances that may arise
after the date hereof. BioShield is a trademark of IBCI.


Make Your Opinion Count - Click Here
http://tbutton.prnewswire.com/prn/11690X88264448

SOURCE International BioChemical Industries, Inc.


CONTACT: Deirdre Baker, General Manager, International BioChemical
Industries, Inc., +1-770-925-3653

URL: http://www.bioshield.net
http://www.prnewswire.com

Copyright (C) 2002 PR Newswire. All rights reserved.

-0-


KEYWORD: Georgia


Ty is the first loser.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.